Usted buscó: data entered is not encrypted (Inglés - Croata)

number of data entered
broj unijetih podataka

is not
nije

the address you have entered is not valid.
adresa koju ste unijeli nije valjana.

it is not.
jer nije.

in vivo interaction data is not available.
podaci o interakcijama in vivo nisu dostupni.

administration is not
rifabutinom neophodno, treba

is not recommended.
atazanavira/ritonavira se ne preporučuje.

the information you have entered is invalid.
informacije koje ste unjeli nisu valjane.

entered column alias "%1" is not a valid identifier.
nevaljana vrsta

the url you entered is not valid, please correct it and try again.
unesena url adresa nije valjana. ispravite ju i pokušajte ponovo.

the e-mail address you have entered is invalid.
e-mail adresa koju ste naveli nije ispravna.

access to standardised data on energy costs is not easy.
pristup standardiziranim podatcima o troškovima energije nije lagan.

blanket surveillance of electronic communications data is not acceptable."
sveobuhvatni nadzor podataka elektroničke komunikacije nije prihvatljiv.”

data coming from publicly funded research is not always open;
podacima proizašlim iz javno financiranih istraživanja nije uvijek moguće pristupiti;

as only limited data are available the clinical significance is not known.
dostupni samo ograničeni podaci te klinička značajnost nije poznata.

the data you have entered is invalid. please check the information you have given by the marked fields.
podaci koje ste unjeli nisu valjani. molimo pogledajte podatke u označenim poljima.

based on data from other cyp3a4 inhibitors, a marked increase is not expected.
s obzirom na podatke o drugim inhibitorima cyp3a4, ne očekuje se značajno povećanje.

due to the lack of data, coadministration of daklinza and etravirine or nevirapine is not recommended.
zbog nedostatka podataka ne preporučuje se istodobna primjena lijeka daklinza s etravirinom ili nevirapinom.

based on these preliminary data, the concurrent administration of ipilimumab and vemurafenib is not recommended.
na temelju tih početnih podataka, ne preporučuje se istovremena primjena ipilimumaba i vemurafeniba.

therefore, in the absence of data, treatment beyond one year is not recommended in these patients.
stoga se u ovih bolesnika, zbog nedostatka podataka, ne preporučuje liječenje u trajanju duljem od godinu dana.